Ategra Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,213
Closed -$508K 58
2024
Q1
$508K Sell
3,213
-40
-1% -$6.37K 0.23% 64
2023
Q4
$510K Sell
3,253
-422
-11% -$64.7K 0.22% 58
2023
Q3
$572K Sell
3,675
-99
-3% -$16.3K 0.31% 55
2023
Q2
$625K Buy
3,774
+22
+0.6% +$3.55K 0.34% 55
2023
Q1
$582K Hold
3,752
0.32% 60
2022
Q4
$663K Hold
3,752
0.34% 59
2022
Q3
$613K Sell
3,752
-40
-1% -$6.77K 0.32% 59
2022
Q2
$673K Hold
3,792
0.34% 58
2022
Q1
$672K Buy
3,792
+40
+1% +$6.81K 0.29% 63
2021
Q4
$642K Sell
3,752
-298
-7% -$48.8K 0.28% 65
2021
Q3
$654K Hold
4,050
0.31% 63
2021
Q2
$667K Hold
4,050
0.32% 58
2021
Q1
$666K Buy
4,050
+228
+6% +$36.9K 0.37% 53
2020
Q4
$602K Sell
3,822
-253
-6% -$37.3K 0.42% 51
2020
Q3
$607K Hold
4,075
0.54% 43
2020
Q2
$573K Buy
4,075
+5
+0.1% +$729 0.55% 38
2020
Q1
$534K Buy
4,070
+25
+0.6% +$3.55K 0.63% 32
2019
Q4
$590K Sell
4,045
-119
-3% -$16.1K 0.49% 40
2019
Q3
$539K Hold
4,164
0.49% 44
2019
Q2
$580K Hold
4,164
0.54% 40
2019
Q1
$582K Buy
+4,164
New +$558K 0.57% 36

Other funds holding JNJ

Ategra Capital Management's JNJ Position: Q2 2024 in Review

Ategra Capital Management sold out of Johnson & Johnson (JNJ) in Q2 2024, closing a stake of 3,213 shares — an estimated $508K sold.

Ategra Capital Management first reported a position in JNJ in Q1 2019 and held it in 21 quarters. The position peaked at $673K in Q2 2022. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

  • Ategra Capital Management reported no remaining Johnson & Johnson position as of Q2 2024 after selling out during the quarter.
  • Ategra Capital Management sold 3,213 Johnson & Johnson shares in Q2 2024, an estimated $508K.
  • Ategra Capital Management first reported a position in Johnson & Johnson in Q1 2019 and held it in 21 quarters.
  • Ategra Capital Management's Johnson & Johnson position peaked at $673K in Q2 2022.
  • 3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on Ategra Capital Management's 13F filing for Q2 2024, filed 14 Feb 2025.